159 related articles for article (PubMed ID: 22288411)
1. Classes of sigma2 (σ2) receptor ligands: structure affinity relationship (SAfiR) studies and antiproliferative activity.
Abate C; Perrone R; Berardi F
Curr Pharm Des; 2012; 18(7):938-49. PubMed ID: 22288411
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and structure-activity relationship studies of conformationally flexible tetrahydroisoquinolinyl triazole carboxamide and triazole substituted benzamide analogues as σ2 receptor ligands.
Bai S; Li S; Xu J; Peng X; Sai K; Chu W; Tu Z; Zeng C; Mach RH
J Med Chem; 2014 May; 57(10):4239-51. PubMed ID: 24821398
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and Pharmacological Evaluation of σ2 Receptor Ligands Based on a 3-Alkoxyisoxazole Scaffold: Potential Antitumor Effects against Osteosarcoma.
Shi JJ; Jia KH; Sun H; Gunosewoyo H; Yang F; Tang J; Luo J; Yu LF
ChemMedChem; 2021 Feb; 16(3):524-536. PubMed ID: 32964625
[TBL] [Abstract][Full Text] [Related]
4. SYA 013 analogs as moderately selective sigma-2 (σ
Al-Ghanim L; Zhu XY; Asong G; Ablordeppey SY
Bioorg Med Chem; 2019 Jun; 27(12):2421-2426. PubMed ID: 30737135
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and quantitative structure-activity relationships of N-(1-benzylpiperidin-4-yl)phenylacetamides and related analogues as potent and selective sigma1 receptor ligands.
Huang Y; Hammond PS; Whirrett BR; Kuhner RJ; Wu L; Childers SR; Mach RH
J Med Chem; 1998 Jun; 41(13):2361-70. PubMed ID: 9632369
[TBL] [Abstract][Full Text] [Related]
6. A structure-affinity and comparative molecular field analysis of sigma-2 (sigma2) receptor ligands.
Abate C; Mosier PD; Berardi F; Glennon RA
Cent Nerv Syst Agents Med Chem; 2009 Sep; 9(3):246-57. PubMed ID: 20021358
[TBL] [Abstract][Full Text] [Related]
7. Antiproliferative and cytotoxic effects of some sigma2 agonists and sigma1 antagonists in tumour cell lines.
Colabufo NA; Berardi F; Contino M; Niso M; Abate C; Perrone R; Tortorella V
Naunyn Schmiedebergs Arch Pharmacol; 2004 Aug; 370(2):106-13. PubMed ID: 15322732
[TBL] [Abstract][Full Text] [Related]
8. Structure-Affinity Relationships of Fluorinated Spirocyclic σ
Bergkemper M; Kronenberg E; Schepmann D; Ludwig FA; Brust P; Wünsch B
ChemMedChem; 2019 Aug; 14(15):1392-1402. PubMed ID: 31189022
[TBL] [Abstract][Full Text] [Related]
9. Hyphenated 3D-QSAR statistical model-scaffold hopping analysis for the identification of potentially potent and selective sigma-2 receptor ligands.
Floresta G; Rescifina A; Marrazzo A; Dichiara M; Pistarà V; Pittalà V; Prezzavento O; Amata E
Eur J Med Chem; 2017 Oct; 139():884-891. PubMed ID: 28866257
[TBL] [Abstract][Full Text] [Related]
10. Structure-Activity Relationships within a Series of σ
Franchini S; Sorbi C; Battisti UM; Tait A; Bencheva LI; Cichero E; Fossa P; Cilia A; Prezzavento O; Ronsisvalle S; Aricò G; Benassi L; Vaschieri C; Azzoni P; Magnoni C; Brasili L
ChemMedChem; 2017 Nov; 12(22):1893-1905. PubMed ID: 28940806
[TBL] [Abstract][Full Text] [Related]
11. Current development of sigma-2 receptor radioligands as potential tumor imaging agents.
Shaghaghi Z; Alvandi M; Ghanbarimasir Z; Farzipour S; Emami S
Bioorg Chem; 2021 Oct; 115():105163. PubMed ID: 34289426
[TBL] [Abstract][Full Text] [Related]
12. The Evolution of the Sigma-2 (σ
Zeng C; Mach RH
Adv Exp Med Biol; 2017; 964():49-61. PubMed ID: 28315264
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, in vitro and in vivo characterization of new benzoxazole and benzothiazole-based sigma receptor ligands.
Romeo G; Prezzavento O; Intagliata S; Pittalà V; Modica MN; Marrazzo A; Turnaturi R; Parenti C; Chiechio S; Arena E; Campisi A; Sposito G; Salerno L
Eur J Med Chem; 2019 Jul; 174():226-235. PubMed ID: 31042618
[TBL] [Abstract][Full Text] [Related]
14.
Wang L; Ye J; He Y; Deuther-Conrad W; Zhang J; Zhang X; Cui M; Steinbach J; Huang Y; Brust P; Jia H
Bioorg Med Chem; 2017 Jul; 25(14):3792-3802. PubMed ID: 28549890
[TBL] [Abstract][Full Text] [Related]
15. Reevaluation of fenpropimorph as a σ receptor ligand: Structure-affinity relationship studies at human σ
Sguazzini E; Schmidt HR; Iyer KA; Kruse AC; Dukat M
Bioorg Med Chem Lett; 2017 Jul; 27(13):2912-2919. PubMed ID: 28495085
[TBL] [Abstract][Full Text] [Related]
16. Pharmacophore models and development of spirocyclic ligands for σ1 receptors.
Wunsch B
Curr Pharm Des; 2012; 18(7):930-7. PubMed ID: 22288413
[TBL] [Abstract][Full Text] [Related]
17. Recent Advances in the Development of Sigma Receptor Ligands as Cytotoxic Agents: A Medicinal Chemistry Perspective.
Fallica AN; Pittalà V; Modica MN; Salerno L; Romeo G; Marrazzo A; Helal MA; Intagliata S
J Med Chem; 2021 Jun; 64(12):7926-7962. PubMed ID: 34076441
[TBL] [Abstract][Full Text] [Related]
18. Development of a Sigma-2 Receptor affinity filter through a Monte Carlo based QSAR analysis.
Rescifina A; Floresta G; Marrazzo A; Parenti C; Prezzavento O; Nastasi G; Dichiara M; Amata E
Eur J Pharm Sci; 2017 Aug; 106():94-101. PubMed ID: 28571781
[TBL] [Abstract][Full Text] [Related]
19. Novel derivatives of 1-cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine (PB28) with improved fluorescent and σ receptors binding properties.
Abate C; Niso M; Marottoli R; Riganti C; Ghigo D; Ferorelli S; Ossato G; Perrone R; Lacivita E; Lamb DC; Berardi F
J Med Chem; 2014 Apr; 57(8):3314-23. PubMed ID: 24697311
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of σ Receptor Ligands with a Spirocyclic System Connected with a Tetrahydroisoquinoline Moiety via Different Linkers.
Bergkemper M; Schepmann D; Wünsch B
ChemMedChem; 2021 Apr; 16(7):1184-1197. PubMed ID: 33332704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
